SCHEMBL25868685

SCHEMBL25868685

Cc1c2ccccc2c2c3c(cccc13)C(=O)N(CN)C2=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 6/20 0.43
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
USP2 O75604 4/20 0.43
KEAP1 Q14145 3/20 0.43
NFE2L2 Q16236 3/20 0.43
ATM Q13315 2/20 0.43
MAPT P10636 4/20 0.42
ALDH1A1 P00352 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
APAF1 O14727 1/20 0.42
GAA P10253 1/20 0.42
THRB P10828 1/20 0.42
LMNA P02545 3/20 0.41
HTT P42858 2/20 0.41
TNNI3 P19429 1/20 0.41
TNNT2 P45379 1/20 0.41
TNNC1 P63316 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9929137 0.81 HPGD (0.44) CYP1B1MEN1KMT2AKEAP1NFE2L2
SCHEMBL1014385 0.72 CA12 (0.54) MEN1KMT2AALDH1A1SMN1; SMN2GAA
SCHEMBL587124 0.72 CES1 (0.54) MEN1KMT2AUSP2ATMMAPT
SCHEMBL13207607 0.71 HEXA (0.73) CYP1B1MEN1KMT2AMAPTALDH1A1
Hydrochloric Acid SCHEMBL9429609 0.70 CA12 (0.52) MEN1KMT2AALDH1A1SMN1; SMN2HEXA
SCHEMBL17557098 0.69 HEXA (0.59) MEN1KMT2AKEAP1NFE2L2MAPT
SCHEMBL8547705 0.69 TYMS (0.46) MEN1KMT2AUSP2ATMMAPT
SCHEMBL19245282 0.68 TERT (0.50) CYP1B1MEN1KMT2AUSP2KEAP1
SCHEMBL14560580 0.66 CYP1B1 (0.62) CYP1B1MEN1KMT2AUSP2KEAP1
SCHEMBL19302158 0.66 TERT (0.56) CYP1B1MEN1KMT2AUSP2KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4215521-A1 FUSED RING DIIMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF Xiangbei Welman Pharmaceutical Co., Ltd (CN) 2023-07-26 EP disclosed